Kymera Therapeutics Logo

Kymera Therapeutics

Director, Business Development

Posted 10 Days Ago
Be an Early Applicant
In-Office
Watertown, MA, USA
195K-275K Annually
Senior level
In-Office
Watertown, MA, USA
195K-275K Annually
Senior level
Lead Kymera's business development strategy by sourcing, evaluating, negotiating, and closing collaborations and licensing deals. Manage transactions end-to-end, coordinate cross-functional diligence, prepare partnering materials and financial analyses (NPV, forecasts, comparables), negotiate agreements, and represent the company at industry events to build strategic partnerships.
The summary above was generated by AI
Who we are:

Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn. 


How we work:
  • PIONEER: We are courageous, resilient and rigorous in our mission to improve patients’ lives through our revolutionary degrader medicines.
  • COLLABORATE: We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine.
  • BELONG: We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard.

                                                                                                                                                                                

How you’ll make an impact:
  • Drive Kymera's business development strategy, positioning our targeted protein degradation platform and pipeline at the center of strategic partnerships.
  • Identify, evaluate, and close strategic transactions with leading biopharma companies— spanning both buy- and sell-side opportunities.
  • Own transactions end to end, from initial opportunity through signature agreement, working closely with R&D, legal, finance, and outside counsel.
  • Lead and coordinate cross-functional diligence teams.
  • Prepare high-quality partnering materials, including presentations, term sheets, valuation models to support transaction processes.
  • Lead search and evaluation processes for prioritized external opportunities.
  • Develop financial analyses, including forecasts, comparables, and NPV valuations, to inform critical decisions.
  • Lead negotiation and execution of collaboration agreements (licensing and collaboration agreements, SRAs, MTAs, and CDAs) in close partnership with internal and external council.
  • Represent Kymera in the industry, building relationships with BD counterparts at current and potential partner companies
  • Represent Kymera at partnering conferences and industry events (eg. JPM, BIO) to build and maintain relationships with potential partners and support S&E activity.

Skills and experience you’ll bring:
  • An advanced degree — PhD, MD, or MBA — that reflects both scientific fluency and business acumen.
  • 8+ years of experience in business development, corporate development, or strategy consulting in biopharma.
  • Experience across the full deal lifecycle: sourcing, diligence, negotiation, and structuring.
  • Demonstrated success working with cross-functional teams and managing multiple concurrent projects
  • Strong strategic judgment, the ability to work independently and represent Kymera externally
  • NPV modeling, forecasting, and comparables analysis with the ability to communicate results clearly.
  • A track record of evaluating opportunities from both a scientific and commercial perspective.
  • Working knowledge of biopharma R&D (experience with small molecules is a plus), clinical development, and regulatory pathways
  • Excellent negotiation, written, and presentation skills.

 

Equal Employment Opportunity

Kymera Therapeutics is proud to be an equal opportunity employer, seeking to create a welcoming and diverse environment.  All applicants will receive consideration for employment without regard to race, color, religion, creed, gender, national origin, age, disability, veteran status, pregnancy, sex, marital status, gender expression or identity, genetic information, sexual orientation, citizenship, or any other legally protected class.


Compensation

  • Kymera offers a competitive compensation package that recognizes both results and capabilities through market-based, performance-driven pay.
  • The anticipated base salary range for this role is $195,000 – $275,000, with eligibility for annual bonus, equity participation, and comprehensive benefits.
  • Actual salary is based on a holistic evaluation of the specific role/level as well as each candidate’s depth of experience and the capabilities they bring to the position.


HQ

Kymera Therapeutics Watertown, Massachusetts, USA Office

500 North Beacon Street, 4th Floor, Watertown, Massachusetts, United States, 02472

Similar Jobs

3 Days Ago
Hybrid
Cambridge, MA, USA
225K-280K Annually
Mid level
225K-280K Annually
Mid level
Healthtech • Machine Learning • Software • Biotech • Pharmaceutical
Lead sourcing, evaluating, and executing licensing, research collaborations, and strategic partnerships across therapeutics. Manage full deal lifecycle: opportunity scouting, due diligence, term sheet negotiation, and agreement execution. Coordinate cross-functional teams (R&D, Legal, Finance), maintain partner relationships, and represent the company at industry conferences.
22 Days Ago
Remote or Hybrid
Massachusetts, USA
104K-186K Annually
Senior level
104K-186K Annually
Senior level
Artificial Intelligence • Big Data • Healthtech • Software • Biotech
Lead business development and strategic account growth with pharmaceutical and mid-sized biopharma partners for NGS, biomarker discovery, clinical trial assays and CDx solutions. Build and maintain pipeline in Salesforce, develop proposals, negotiate and close deals, and collaborate cross-functionally to deliver signed engagements. Travel internationally (~30%) to meet customers and attend events, focusing on new customer acquisition across Europe and the US East Coast.
Top Skills: Companion Diagnostics (Cdx)CtdnaMsk AccessNext-Generation Sequencing (Ngs)SalesforceSophia Ddm
8 Days Ago
In-Office
Needham, MA, USA
200K-240K Annually
Senior level
200K-240K Annually
Senior level
Beauty • Robotics • Design • Appliances • Manufacturing
Lead creation of entirely new consumer product categories end-to-end: define vision, size markets, build financial cases, ideate and screen product concepts, drive early development and partnerships, and present fundable business cases to executive leadership to launch roadmap-ready opportunities.

What you need to know about the Boston Tech Scene

Boston is a powerhouse for technology innovation thanks to world-class research universities like MIT and Harvard and a robust pipeline of venture capital investment. Host to the first telephone call and one of the first general-purpose computers ever put into use, Boston is now a hub for biotechnology, robotics and artificial intelligence — though it’s also home to several B2B software giants. So it’s no surprise that the city consistently ranks among the greatest startup ecosystems in the world.

Key Facts About Boston Tech

  • Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
  • Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
  • Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
  • Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
  • Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
  • Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account